A US-based rheumatologist discusses the intricacies of diagnosing Sjögren’s, including the wide variety of symptoms, as well as their treatment paradigm for a disease with no FDA-approved advanced therapies and their perspective on key pipeline agents. 

This interview was conducted on March 6, 2025.

If you are a Datamonitor Healthcare client, you may access the interview from our KOL Insight channel. 

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.  

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900.  

For our disclosures, please read the Biomedtracker Research Standards.